Carregant...
Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis
Visceral leishmaniasis (VL) is a tropical infectious disease, which is called Mediterranean visceral leishmaniasis (MVL) in the Mediterranean area. In spite of many attempts, no effective commercial vaccine exists for MVL. To find new targets for developing antileishmanial vaccines, knowing parasite...
Guardat en:
| Publicat a: | J Parasit Dis |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer India
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5962495/ https://ncbi.nlm.nih.gov/pubmed/29844618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12639-018-0986-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|